The company has started roadshow for the launch.
Kenvue IPO offers 151,204,000 shares of its common stock
IPO price will be between $20.00 and $23.00 per share
Will be listed on the New York Stock Exchange under the symbol “KVUE.”
Johnson & Johnson will own 1,716,160,000 shares of Kenvue’s common stock (91.9%)
Goldman Sachs & Co. LLC, J.P. Morgan and BofA Securities are lead running book managers
The IPO will generate net proceeds of around $3.15 million
To pay for the Business that Johnson & Johnson is transferring to Kenvue Inc. in connection with the Separation.
Kenvue raised US$7.75bn on 8th March 2023, from its inaugural bond offering prior to the initial public offering.
Kenvue is the largest pure-play consumer health company by revenue with $15.1 billion in net sales in 2021.
Ten of its brands had over $400 million in net sales in 2021.
The company currently holds five #1 brand positions across major categories globally
Kenvue presents across the regions. Over half of its net sales were generated outside North America in 2021.
Net sales increased from $14.3 billion to $15.1 billion
Net income increased from $1.4 billion to $2.0 billion
Adjusted EBITDA increased from $3.4 billion to $3.9 billion
Adjusted net income increased from $2.2 billion to $2.8 billion
Net cash flow from operating activities increased from $ 2.99 billion to $3.4 billion
After the IPO, J&J will retain at least 80.1% of Kenvue's shares but plans to distribute that stake to its own shareholders.
Thibaut Mongon is the Chief Executive Officer and Director of the company
Luani Alvarado is the Chief Financial Officer of the company.
The consumer health market is expected to grow at a CAGR of 4% globally from 2022 to 2025.
J&J is one of the well-known brand worldwide.
Global leader in healthcare and consumer goods
Strong parental – “Jonson and Jonson”
Presence across product categories and geographics
Kenvue’s products are available in over 165 countries and 25 in-house manufacturing facilities
Recession-resistant business with hefty cashflows.
Actively expanding through acquisitions toward high-growth and high-margin businesses.
I would love to invest in the company for the long term
JnJ stock has been performing consistently over the last 5 years
Kenvue Stock will perform well in long term.
Please comment if you would like to see it in different way